Study Indicates That Monosodium Glutamate May Help in the Treatment of People with Dementia

May 2021 – Research conducted by Tottori University in Japan concluded that monosodium glutamate (MSG) is beneficial in supporting the treatment of dementia by reducing the overall cognitive deficit.

The results were published in the second half of 2018 in an article in the European Journal of Clinical Nutrition, an international journal specializing in covering aspects of nutritional sciences. The study evaluates MSG’s potential to positively contribute to slowing the progression of the disease.

During the course of the experiment, researchers concluded that patients who added the additive to their diet showed greater stimulation in food acceptance, considering that loss of appetite is regarded as an important risk factor for the progression of dementia in elderly patients.

For more information, the study is available digitally, in English: https://www.nature.com/articles/s41430-018-0349-x

Umami

Umami is the fifth basic taste of the human palate, discovered in 1908 by Japanese scientist Kikunae Ikeda. It was scientifically recognized in 2000, when researchers at the University of Miami confirmed the existence of specific receptors for this taste in the taste buds. The amino acid glutamic acid and the nucleotides inosinate and guanylate are the main umami substances. The two main characteristics of umami are the increase in salivation and the persistence of taste for a few minutes after eating. To learn more, visit www.portalumami.com.br.